Top Tweets for #CAMOLDX

Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity [Sep 10, 2025] Davis et al. @CCR_AACR
https://t.co/eY0etUfQhQ #bcsm #PrecisionMedicine #camoldx @TempusAI
![mtmdphd's tweet photo. Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity [Sep 10, 2025] Davis et al. @CCR_AACR
https://t.co/eY0etUfQhQ #bcsm #PrecisionMedicine #camoldx @TempusAI https://t.co/WBcB4uGito](https://pbs.twimg.com/media/HHAAwKZbwAIau6J.png)
How I manage patients with unexplained cytopenia [Apr 10, 2025] Malcovati & Cazzola @BloodPortfolio https://t.co/bfCmp1AJ4R #camoldx #PrecisionMedicine
![mtmdphd's tweet photo. How I manage patients with unexplained cytopenia [Apr 10, 2025] Malcovati & Cazzola @BloodPortfolio https://t.co/bfCmp1AJ4R #camoldx #PrecisionMedicine https://t.co/LpQhp9W79v](https://pbs.twimg.com/media/HG3zVrzXEAAVdu4.jpg)
Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity [Sep 10, 2025] Davis et al. @CCR_AACR
https://t.co/eY0etUfQhQ #bcsm #PrecisionMedicine #camoldx @TempusAI
![mtmdphd's tweet photo. Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity [Sep 10, 2025] Davis et al. @CCR_AACR
https://t.co/eY0etUfQhQ #bcsm #PrecisionMedicine #camoldx @TempusAI https://t.co/oDkC1Ua6DS](https://pbs.twimg.com/media/HF3_Xn6XMAABN_p.jpg)
The multiple myelomas -- current concepts in cytogenetic classification and therapy [Apr 23, 2018] @myelomaMD & @VincentRK @NatRevClinOncol https://t.co/X3PTB3bzXD #mmsm #camoldx
![mtmdphd's tweet photo. The multiple myelomas -- current concepts in cytogenetic classification and therapy [Apr 23, 2018] @myelomaMD & @VincentRK @NatRevClinOncol https://t.co/X3PTB3bzXD #mmsm #camoldx https://t.co/utKO6I2LWx](https://pbs.twimg.com/media/HBmmABcWkAA4_K5.jpg)
Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers [Oct 4, 2010] Von Hoff et al. @JCO_ASCO https://t.co/VwZjTf86Pp #PrecisionMedicine #camoldx #ctsm
![mtmdphd's tweet photo. Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers [Oct 4, 2010] Von Hoff et al. @JCO_ASCO https://t.co/VwZjTf86Pp #PrecisionMedicine #camoldx #ctsm https://t.co/IggyPtzCAI](https://pbs.twimg.com/media/HAUVmdgWAAAEU84.jpg)
How I manage patients with unexplained cytopenia [Apr 10, 2025] Malcovati & Cazzola @BloodPortfolio https://t.co/bfCmp1AJ4R #camoldx #PrecisionMedicine
![mtmdphd's tweet photo. How I manage patients with unexplained cytopenia [Apr 10, 2025] Malcovati & Cazzola @BloodPortfolio https://t.co/bfCmp1AJ4R #camoldx #PrecisionMedicine https://t.co/u2W3NpfXNX](https://pbs.twimg.com/media/G7vEZwkXEAENpHc.jpg)
Separating Innocuous “CHIP” Mutations From Ominous “CHOP” Mutations in Patients With Treated AML in Remission [Oct 11, 2021] Fitzpatrick & Hasserjian @ASH_hematology The Hematologist https://t.co/WmobwY3wG2 #AML #leusm #mdssm #camoldx
![mtmdphd's tweet photo. Separating Innocuous “CHIP” Mutations From Ominous “CHOP” Mutations in Patients With Treated AML in Remission [Oct 11, 2021] Fitzpatrick & Hasserjian @ASH_hematology The Hematologist https://t.co/WmobwY3wG2 #AML #leusm #mdssm #camoldx https://t.co/Rfv4sSNCLT](https://pbs.twimg.com/media/G7vEQHHX0AALK5l.jpg)
How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes [Sep 5, 2018] @DavidSteensma @BloodJournal https://t.co/MsnBSpHtvo #MDSsm #camoldx
![mtmdphd's tweet photo. How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes [Sep 5, 2018] @DavidSteensma @BloodJournal https://t.co/MsnBSpHtvo #MDSsm #camoldx https://t.co/e1SuIBCuSm](https://pbs.twimg.com/media/G7vD_m1WkAA-D6v.png)
Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia [Apr 27, 2018] Morita, @DrHKantarjian et al. @JCO_ASCO https://t.co/81RqI8nANC #leusm #AMLsm #camoldx
![mtmdphd's tweet photo. Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia [Apr 27, 2018] Morita, @DrHKantarjian et al. @JCO_ASCO https://t.co/81RqI8nANC #leusm #AMLsm #camoldx https://t.co/EmW4wmcqlC](https://pbs.twimg.com/media/G7vD6eBWsAEzkuE.png)
CHIP, ICUS, CCUS and other four-letter words [Jun 8, 2017] Bejar @LeukemiaJnl https://t.co/KIC78XHsHd #leusm #mdssm #camoldx
![mtmdphd's tweet photo. CHIP, ICUS, CCUS and other four-letter words [Jun 8, 2017] Bejar @LeukemiaJnl https://t.co/KIC78XHsHd #leusm #mdssm #camoldx https://t.co/CZmClUdhG9](https://pbs.twimg.com/media/G7vD2a-WAAE_KqS.png)
European Myeloma Network [EMN] Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma [Oct 13, 2025] @nickbolli et al. @Hemasphere_EHA
https://t.co/1rzacJDadV #mmsm #camoldx #PrecisionMedicine
![mtmdphd's tweet photo. European Myeloma Network [EMN] Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma [Oct 13, 2025] @nickbolli et al. @Hemasphere_EHA
https://t.co/1rzacJDadV #mmsm #camoldx #PrecisionMedicine https://t.co/MJA9w3n8gd](https://pbs.twimg.com/media/G7mm-LXWcAAgRRm.jpg)
FAM46C/Tent5c inactivation accelerates multiple myeloma progression from early stages & remodels the bone marrow immune microenvironment in preclinical models [Nov 3, 2025] Carmen Vicente et al. #ASH25 abs25-2794 PID 1027 https://t.co/bq1Nq7tS8Y #mnmsm #camoldx #camicroenv
![mtmdphd's tweet photo. FAM46C/Tent5c inactivation accelerates multiple myeloma progression from early stages & remodels the bone marrow immune microenvironment in preclinical models [Nov 3, 2025] Carmen Vicente et al. #ASH25 abs25-2794 PID 1027 https://t.co/bq1Nq7tS8Y #mnmsm #camoldx #camicroenv https://t.co/kUHHcer0Oo](https://pbs.twimg.com/media/G5jvpPMWsAA0kqi.png)
European Myeloma Network [EMN] Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma [Oct 13, 2025] @nickbolli et al. @Hemasphere_EHA
https://t.co/1rzacJCCon #mmsm #camoldx #PrecisionMedicine
![mtmdphd's tweet photo. European Myeloma Network [EMN] Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma [Oct 13, 2025] @nickbolli et al. @Hemasphere_EHA
https://t.co/1rzacJCCon #mmsm #camoldx #PrecisionMedicine https://t.co/QapO1TsQQt](https://pbs.twimg.com/media/G5A4yPKWkAA_uzW.jpg)
Last Seen Hashtags on Sotwe
momson nolimit() +filter:native_video
Seen from Spain
vafollowers
Seen from United States
电击乳夹
Seen from United States
北杜市大泉町
Seen from Japan
monkeyappwinsFull
Seen from United States
MagsMx
Seen from Ecuador
OTD
Seen from United States
motherson
Seen from Mexico
WelcomeToJakartaDreamies
Seen from United States
hataygay
Seen from Turkey
Most Popular Users

Elon Musk 
@elonmusk
241M followers

Barack Obama 
@barackobama
119.2M followers

Cristiano Ronaldo 
@cristiano
112.1M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107.1M followers

Rihanna 
@rihanna
98.1M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91.3M followers

KATY PERRY 
@katyperry
88.5M followers

Taylor Swift 
@taylorswift13
82.4M followers

Lady Gaga 
@ladygaga
73.9M followers

Virat Kohli 
@imvkohli
71.2M followers

Kim Kardashian 
@kimkardashian
70.2M followers

YouTube 
@youtube
68.7M followers

Bill Gates 
@billgates
64.4M followers

Neymar Jr 
@neymarjr
64.1M followers

The Ellen Show
@theellenshow
62.4M followers

CNN 
@cnn
61.8M followers

Selena Gomez 
@selenagomez
61.6M followers

X 
@x
60.8M followers

![mtmdphd's tweet photo. Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity [Sep 10, 2025] Davis et al. @CCR_AACR
https://t.co/eY0etUfQhQ #bcsm #PrecisionMedicine #camoldx @TempusAI https://t.co/oDkC1Ua6DS](https://pbs.twimg.com/media/HF3_WrTasAUL-Uw.png)
![mtmdphd's tweet photo. Pilot Study Using Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers [Oct 4, 2010] Von Hoff et al. @JCO_ASCO https://t.co/VwZjTf86Pp #PrecisionMedicine #camoldx #ctsm https://t.co/IggyPtzCAI](https://pbs.twimg.com/media/HAUVlMvXMAAQwal.jpg)
![mtmdphd's tweet photo. Clinical Utility of Targeted Next-Generation [NGS] Screening of Peripheral Blood in the Evaluation of Patients with Cytopenias [Oct 10, 2019] Shanmugam et al. @BloodJournal https://t.co/kn6EmEbaIn #camoldx #mpnsm #leusm https://t.co/X7D2S7ln1P](https://pbs.twimg.com/media/G7vEH8ZXgAAGx30.jpg)
![mtmdphd's tweet photo. CHIP, ICUS, CCUS and other four-letter words [Jun 8, 2017] Bejar @LeukemiaJnl https://t.co/KIC78XHsHd #leusm #mdssm #camoldx https://t.co/CZmClUdhG9](https://pbs.twimg.com/media/G7vD1GeXMAAZ-Vo.jpg)
![mtmdphd's tweet photo. Whole genome sequencing (WGS) uncovers novel BCR::ABL1 breakpoints and variants in leukemia: Implications for personalized medicine [Nov 3, 2025] Huether et al. Nimeiri #ASH25 abs25-11626 PID 6130 https://t.co/FcU9Jgl2Hb #leusm #cagenome #PrecisionMedicine #camoldx @TempusAI https://t.co/6x3RfpooyA](https://pbs.twimg.com/media/G7P8UKHWQAA7TVB.jpg)
![mtmdphd's tweet photo. Whole genome sequencing (WGS) uncovers novel BCR::ABL1 breakpoints and variants in leukemia: Implications for personalized medicine [Nov 3, 2025] Huether et al. Nimeiri #ASH25 abs25-11626 PID 6130 https://t.co/FcU9Jgl2Hb #leusm #cagenome #PrecisionMedicine #camoldx @TempusAI https://t.co/px0OBw8FHu](https://pbs.twimg.com/media/G6JMlDmWEAAwQQN.jpg)
![mtmdphd's tweet photo. Whole genome sequencing (WGS) uncovers novel BCR::ABL1 breakpoints and variants in leukemia: Implications for personalized medicine [Nov 3, 2025] Huether et al. Nimeiri #ASH25 abs25-11626 PID 6130 https://t.co/FcU9JglAwJ #leusm #cagenome #PrecisionMedicine #camoldx @TempusAI https://t.co/108rggT8Ux](https://pbs.twimg.com/media/G5lcsuRWYAAtuRk.jpg)
![mtmdphd's tweet photo. Whole genome sequencing (WGS) uncovers novel BCR::ABL1 breakpoints and variants in leukemia: Implications for personalized medicine [Nov 3, 2025] Huether et al. Nimeiri #ASH25 Abstract 11626 https://t.co/FcU9Jgl2Hb #leusm #cagenome #PrecisionMedicine #camoldx @TempusAI https://t.co/POF9UQP5MH](https://pbs.twimg.com/media/G5ZoK-YXYAEyk0Z.jpg)
![mtmdphd's tweet photo. Whole genome sequencing (WGS) uncovers novel BCR::ABL1 breakpoints and variants in leukemia: Implications for personalized medicine [Nov 3, 2025] Huether et al. Nimeiri #ASH25 Abstract 11626 https://t.co/FcU9Jgl2Hb #leusm #cagenome #PrecisionMedicine #camoldx @TempusAI https://t.co/XCeI1LLib3](https://pbs.twimg.com/media/G5FJb2XXsAATM4K.jpg)
![mtmdphd's tweet photo. European Myeloma Network [EMN] Group Consensus Statement on the use of next-generation sequencing for prognostic stratification of newly diagnosed multiple myeloma [Oct 13, 2025] @nickbolli et al. @Hemasphere_EHA
https://t.co/1rzacJCCon #mmsm #camoldx #PrecisionMedicine https://t.co/QapO1TsQQt](https://pbs.twimg.com/media/G5A4v9UXwAA-rnN.jpg)